22 Jul 2021

World's first toxicology testing strategy without animal testing adopted by OECD

The world’s first toxicology testing strategy without animal testing has been approved by the OECD (Organisation for Economic Co-operation and Development). The testing strategy consists of three so-called alternative methods. They can be used to predict whether a substance causes allergic reactions in the skin. Unlike in the past, animal testing will no longer be necessary for this. This testing strategy was developed and validated in a joint effort by BASF and Givaudan. “For more than 10 years, we have been working towards this goal,” says Dr. Robert Landsiedel, Vice President, Special Toxicology, BASF. “We have taken a big step forward. Now we can also use alternative methods to answer more complex toxicological questions without animal testing.” Dr. Andreas Natsch, head of in vitro Molecular Screening at Givaudan adds: “This strategy has a better predictivity for human allergy risks as compared to traditional animal testing.”

See this website or press release for further information.